{"id":1708,"date":"2018-06-11T15:48:12","date_gmt":"2018-06-11T12:48:12","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=1708"},"modified":"2026-10-30T13:29:52","modified_gmt":"2026-10-30T11:29:52","slug":"iasis-pharma-participation-at-the-14th-panhellenic-conference-on-obstetrics-and-gynecology","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-at-the-14th-panhellenic-conference-on-obstetrics-and-gynecology\/","title":{"rendered":"IASIS PHARMA PARTICIPATION AT THE 14th PANHELLENIC CONFERENCE ON OBSTETRICS AND GYNECOLOGY"},"content":{"rendered":"<p><strong>MEGARON ATHENS INTERNATIONAL CONFERENCE CENTRE,<\/strong><br \/>\n<strong> 31\/05 &#8211; 03\/06\/2018<\/strong><\/p>\n<p><strong>\u0399\u0391SIS PHARMA<\/strong>, also contributing to the field of <strong>Gynecology<\/strong>, participated successfully in the <strong>14th Panhellenic Conference <\/strong>on<strong> Obstetrics <\/strong>and<strong> Gynecology<\/strong>, which took place on <strong>May 31st- June 3rd<\/strong>, at <strong>Megaron Athens International Conference Centre<\/strong>.<br \/>\nThe particular meeting is the leading event of the Hellenic Society of Obstetrics and Gyneacology (HSOG). A number of reputable national and international guest speakers participated, introducing the delegates into the latest scientific developments in Obstetrics and Gynecology.<br \/>\nThe Healthcare specialists visited <strong>IASIS PHARMA<\/strong> exhibition stand, where they were informed about the company\u2019s <strong>wide range <\/strong>and<strong> high quality<\/strong> medicinal products.<\/p>\n<p>Increased interest was shown for <strong>Modiwart\u00ae<\/strong>, the new <strong>IASIS PHARMA<\/strong> product, with <strong>imiquimod<\/strong> as its active ingredient. <strong>Modiwart\u00ae<\/strong> is an<em> innovative immunomodulator<\/em>, with the following indications: external genital and anogenital warts (condyloma acuminata) in adults, small superficial basal cell carcinomas (sBCCs) and clinically typical actinic keratosis. <strong>Modiwart\u00ae<\/strong> is available as a cream (5%) for topical use, in single-use sachets (12 per box).<\/p>\n<p>There was also strong interest for the <strong>effervescent line<\/strong> produced in <strong>IASIS PHARMA<\/strong> state of the art, manufacturing unit for pharma grade effervescent products.<br \/>\nMore specifically:<br \/>\n\u2022 <strong>MAG-IASIS\u00ae<\/strong>, a combination of <strong>magnesium citrate and magnesium aspartate dihydrate, equivalent to 243 mg of Magnesium<\/strong><br \/>\n\u2022 <strong>Calciform D3\u00ae<\/strong>, in the <strong>unique combination<\/strong> of <strong>Calcium<\/strong> + <strong>Vitamin D<\/strong>(Calcium carbonate+ Cholecalciferol: 1000mg+880 IU) and<br \/>\n\u2022 <strong>Calciform\u00ae<\/strong>,<strong> Calcium carbonate 500 mg<\/strong>.<\/p>\n<p>Moreover, <strong>Combi\u00ae<\/strong> was introduced\u00b7 as a combination of <strong>miconazole + fluprednidene<\/strong> in the form of <strong>cream<\/strong> with excellent texture and the advantage of the <strong>50g packsize<\/strong>.<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-1705\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-300x225.jpg\" alt=\"pan-syn-maieu\" width=\"533\" height=\"400\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-120x90.jpg 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-200x150.jpg 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-300x225.jpg 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-400x300.jpg 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-500x375.jpg 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-600x450.jpg 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-700x525.jpg 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-768x576.jpg 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-800x600.jpg 800w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-1024x768.jpg 1024w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu-1200x900.jpg 1200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2018\/06\/pan-syn-maieu.jpg 1280w\" sizes=\"(max-width: 533px) 100vw, 533px\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MEGARON ATHENS INTERNATIONAL CONFERENCE CENTRE, 31\/05 &#8211; 03\/06\/2018 \u0399\u0391SIS PHARMA, also contributing to the field of Gynecology, participated successfully in the 14th Panhellenic Conference on Obstetrics and Gynecology, which took place on May 31st- June 3rd, at Megaron Athens International Conference Centre. The particular meeting is the leading event of the Hellenic Society of Obstetrics  [&#8230;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157],"tags":[],"class_list":["post-1708","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-ry","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=1708"}],"version-history":[{"count":5,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1708\/revisions"}],"predecessor-version":[{"id":1710,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/1708\/revisions\/1710"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=1708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=1708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=1708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}